Current Atherosclerosis Reports

, Volume 2, Issue 6, pp 487–493 | Cite as

Diet and coronary heart disease: Clinical trials

  • Margaret E. Brousseau
  • Ernst J. Schaefer

Abstract

Dietary intervention trials using coronary heart disease (CHD) mortality and morbidity as endpoints have demonstrated that restriction of dietary total and saturated fat or replacement of the latter with polyunsaturated fatty acids (PUFAs), in particular n-3 PUFAs, is of great benefit with respect to CHD risk. This is likewise the case for intervention trials using angiographic endpoints, with many studies showing that such diets not only retard progression of coronary atherosclerosis but can cause regression as well. The role that antioxidants, such as vitamin E, may play in the development and progression of CHD is less clear. The results of large-scale clinical trials evaluating the effect of vitamin E supplementation on CHD risk do not support the concept that this agent is cardioprotective. The purpose of this report is to review dietary intervention trials that support a direct relationship between diet, lipoproteins, and CHD risk.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    American Heart Association: 1998 heart and stroke statistical update. Dallas, TX, American Heart Association, 1998:B4.Google Scholar
  2. 2.
    The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988, 148:36–69.CrossRefGoogle Scholar
  3. 3.
    The Expert Panel: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993, 269:3015–3023.CrossRefGoogle Scholar
  4. 4.
    The Expert Panel: Second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994, 89:1333–1345.Google Scholar
  5. 5.
    Spady DK, Bilheimer DW, Dietschy JM: Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci USA 1983, 80:3499–3503.PubMedCrossRefGoogle Scholar
  6. 6.
    Brinton EA, Eisenberg S, Breslow JL: A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest 1990, 85:144–151.PubMedCrossRefGoogle Scholar
  7. 7.
    Velez-Carrasco W, Lichtenstein AH, Welty FK, et al.: Dietary restriction of saturated fat and cholesterol decreases HDL apoA-I secretion. Arterioscler Thromb Vasc Biol 1999, 19:918–924.PubMedGoogle Scholar
  8. 8.
    Yu-Poth S, Zhao G, Etherton T, et al.: Effects of the National Cholesterol Education Program’s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999, 69:632–646.PubMedGoogle Scholar
  9. 9.
    Mattson FH, Grundy SM: Comparison of the effects of dietary saturated, monoun-saturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985, 26:194–202.PubMedGoogle Scholar
  10. 10.
    Dreon DM, Vranizan KM, Krauss RM, et al.: The effects of polyunsaturated fat vs monounsaturated fat on plasma lipoproteins. JAMA 1990, 263:2462–2466.PubMedCrossRefGoogle Scholar
  11. 11.
    Mensink RP, Katan MB: Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911–919.PubMedGoogle Scholar
  12. 12.
    Mensink RP, Katan MB: Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990, 323:439–445.PubMedCrossRefGoogle Scholar
  13. 13.
    Zock PL, Katan MB: Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992, 33:399–410.PubMedGoogle Scholar
  14. 14.
    Judd JT, Clevidence BA, Muesing RA, et al.: Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy subjects. Am J Clin Nutr 1994, 59:861–868.PubMedGoogle Scholar
  15. 15.
    Lichtenstein AH, Ausman LM, Jalbert SM, et al.: Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999, 340:1933–1940.PubMedCrossRefGoogle Scholar
  16. 16.
    Kris-Etherton PM, Yu S: Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 1997, 65:1628S-1644S.PubMedGoogle Scholar
  17. 17.
    Morrison LM: A nutritional program for prolongation of life in coronary atherosclerosis. JAMA 1955, 159:1425–1428.Google Scholar
  18. 18.
    Morrison LM: Diet in coronary atherosclerosis. JAMA 1960, 173:884–888.PubMedGoogle Scholar
  19. 19.
    Nelson AM: Treatment of atherosclerosis by diet. North W Med 1956, 55:643–649.Google Scholar
  20. 20.
    Lyon TP, Yankley A, Gofman JW, et al.: Lipoproteins and diet in coronary heart disease. Calif Med 1956, 84:325–328.PubMedGoogle Scholar
  21. 21.
    Turpeinen O, Roine P, Pekkarinen M, et al.: Effect on serum cholesterol level of replacement of dietary milk fat by soy bean oil. Lancet 1960, 1:196–198.PubMedCrossRefGoogle Scholar
  22. 22.
    Joliffe N, Baumgartner L, Rinzler S, et al.: The Anti-Coronary Club. The first four years. New York St J Med 1963, 63:69–79.Google Scholar
  23. 23.
    Koranyi A: Prophylaxis and treatment of the coronary syndrome. Ther hung 1963, 11:17–20.Google Scholar
  24. 24.
    Bierenbaum ML, Green DP, Florin A, et al.: Modified-fat dietary management of the young male with coronary disease: a five-year report. JAMA 1967, 202:1119–1123.PubMedCrossRefGoogle Scholar
  25. 25.
    Christakis G, Rinzler SH, Archer M, et al.: The anti-coronary club: a dietary approach to the prevention of coronary heart disease: seven-year report. Am J Public Health Nations Health 1966, 56:299–314.PubMedGoogle Scholar
  26. 26.
    Turpeinen O, Miettinen M, Karvonen MJ, et al.: Dietary prevention of coronary heart disease: long-term experiment: I. observations of male subjects. Am J Clin Nutr 1968, 21:255–276.PubMedGoogle Scholar
  27. 27.
    Miettinen M, Turpeinen O, Karvonen MJ, et al.: Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. Lancet 1972, 2:835–838.PubMedCrossRefGoogle Scholar
  28. 28.
    Turpeinen O: Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Circulation 1979, 59:1–7.PubMedGoogle Scholar
  29. 29.
    Leren P: The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. Acta Med Scand 1966, 466:1–92.Google Scholar
  30. 30.
    Dayton S, Pearce ML, Goldman H, et al.: Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet 1968, 2:1060–1062.PubMedCrossRefGoogle Scholar
  31. 31.
    Frantz ID, Jr, Dawson EA, Ashman PL, et al.: Test of effect of lipid lowering by diet on cardiovascular risk: the Minnesota Coronary Survey. Arteriosclerosis 1989, 9:129–135.PubMedGoogle Scholar
  32. 32.
    Blum CB, Levy RI: Epidemiological and public health studies of treatment of hyper-cholesterolemia. In Primary Hyperlipoproteinemias. Edited by Steiner G, Shafrir E. New York, McGraw-Hill, 1991:129.Google Scholar
  33. 33.
    Burr ML, Gilbert JF, Holliday RM, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989, 2:757–761.PubMedCrossRefGoogle Scholar
  34. 34.
    de Lorgeril M, Renaud S, Mamelle N, et al.: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343:1454–1459.PubMedCrossRefGoogle Scholar
  35. 35.
    de Lorgeril M, Salen P, Martin J-L, et al.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779–785.PubMedGoogle Scholar
  36. 36.
    GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447–455.CrossRefGoogle Scholar
  37. 37.
    The HOPE Study Investigators: The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996, 12:127–137.Google Scholar
  38. 38.
    The Heart Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000, 342:154–160.CrossRefGoogle Scholar
  39. 39.
    The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994, 330:1029–1035.CrossRefGoogle Scholar
  40. 40.
    Stephens NG, Parsons A, Schofield PM, et al.: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996, 347:781–786.PubMedCrossRefGoogle Scholar
  41. 41.
    Gould KL, Ornish D, Kirkeeide R, et al.: Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 1992, 69:845–853.PubMedCrossRefGoogle Scholar
  42. 42.
    Ornish DM, Brown SE, Scherwitz LW, et al.: Can lifestyle changes reverse coronary heart disease? Lancet 1990, 336:129–133.PubMedCrossRefGoogle Scholar
  43. 43.
    Ornish DM, Scherwitz LW, Billings JH, et al.: Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998, 280:2001–2007.PubMedCrossRefGoogle Scholar
  44. 44.
    Schuler G, Hambrecht R, Schlierf G, et al.: Regular physical exercise and low-fat diet: effects of progression on coronary artery disease. Circulation 1992, 86:1–11.PubMedGoogle Scholar
  45. 45.
    Blankenhorn DH, Johnson RL, Mack WJ, et al.: The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990, 263:1646–1652.PubMedCrossRefGoogle Scholar
  46. 46.
    Watts GF, Lewis B, Brunt JNH, et al.: Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas’ Atherosclerosis Regression Study (STARS). Lancet 1992, 339:563–569.PubMedCrossRefGoogle Scholar
  47. 47.
    Haskell WL, Alderman EL, Fair JM, et al.: The effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events: the Stanford Coronary Intervention Project (SCRIP). Circulation 1994, 89:975–990.PubMedGoogle Scholar
  48. 48.
    Quinn TG, Alderman EL, McMillan A, et al.: Development of new coronary atherosclerotic lesions during a 4-year multifactor risk reduction program: The Stanford Risk Intervention Project (SCRIP). J Am Coll Cardiol 1994, 24:900–908.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2000

Authors and Affiliations

  • Margaret E. Brousseau
    • 1
  • Ernst J. Schaefer
    • 1
  1. 1.Jean Mayer-USDA Human Nutrition Research Center on AgingTufts UniversityBostonUSA

Personalised recommendations